Prenatal exposure to betamethasone decreases anxiety in developing rats: Hippocampal neuropeptide Y as a target molecule

Neuropsychopharmacology

Volumn 31, Issue 10, 2006, Pages 2140-2149

  Velíšek, Libor ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Anxiety; Betamethasone; Immunohistochemistry; Neuropeptide Y; Prenatal; Repeated exposure

Indexed keywords

BETAMETHASONE; NEUROPEPTIDE Y;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BODY WEIGHT; CHILD BEHAVIOR; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG PROTEIN BINDING; FEAR; FEMALE; FETUS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOTOR PERFORMANCE; NEWBORN; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT; RISK BENEFIT ANALYSIS; THIRD TRIMESTER PREGNANCY; TRANQUILIZING ACTIVITY; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANXIETY; BEHAVIOR, ANIMAL; BETAMETHASONE; BODY WEIGHT; EMBRYO; EXPLORATORY BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; NEUROPEPTIDE Y; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RETENTION (PSYCHOLOGY); SEX FACTORS;

EID: 33748789321     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301016     Document Type: Article

References (77)

1. Aghajafari F, Murphy K, Matthews S, Ohlsson A, Amankwah K, Hannah M (2002). Repeated doses of antenatal corticosteroids in animals: a systematic review. Am J Obstet Gynecol 186: 843-849.
2. Anderson AB, Gennser G, Jeremy JY, Ohrlander S, Sayers L, Turnbull AC (1977). Placental transfer and metabolism of betamethasone in human pregnancy. Obstet Gynecol 49: 471-474.
3. Andrews N, File SE, Fernandes C, Gonzalez LE, Barnes NM (1997). Evidence that the median raphe nucleusFdorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety. Psychopharmacology (Berl) 130: 228-234.
4. Avishai-Eliner S, Brunson KL, Sandman CA, Baram TZ (2002). Stressed-out, or in (utero)? Trends Neurosci 25: 518-524.
5. Bannerman DM, Deacon RM, Offen S, Friswell J, Grubb M, Rawlins JN (2002a). Double dissociation of function within the hippocampus: spatial memory and hyponeophagia. Behav Neurosci 116: 884-901.
6. Bannerman DM, Grubb M, Deacon RM, Yee BK, Feldon J, Rawlins JN (2003). Ventral hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res 139: 197-213.
7. Bannerman DM, Lemaire M, Yee BK, Iversen SD, Oswald CJ, Good MA et al (2002b). Selective cytotoxic lesions of the retrohippocampal region produce a mild deficit in social recognition memory. Exp Brain Res 142: 395-401.
8. Bannerman DM, Rawlins JN, McHugh SB, Deacon RM, Yee BK, Bast T et al (2004). Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 28: 273-283.
9. Bannon AW, Seda J, Carmouche M, Francis JM, Norman MH, Karbon B et al (2000). Behavioral characterization of neuropeptide Y knockout mice. Brain Res 868: 79-87.
10. Barbazanges A, Piazza PV, Le Moal M, Maccari S (1996). Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J Neurosci 16: 3943-3949.
11. Beato M, Sanchez-Pacheco A (1996). Interaction of steroid hormone receptors with the transcription initiation complex. Endocr Rev 17: 587-609.
12. Broderick PA, Hope O, Jeannot P (1998). Mechanism of triazolobenzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animal. Prog Neuropsychopharmacol Biol Psychiatry 22: 353-386.
13. Brunson KL, Kramar E, Lin B, Chen Y, Colgin LL, Yanagihara TK et al (2005). Mechanisms of late-onset cognitive decline after early-life stress. J Neurosci 25: 9328-9338.
14. Carlos RQ, Seidler FJ, Slotkin TA (1992). Fetal dexamethasone exposure alters macromolecular characteristics of rat brain development: a critical period for regionally selective alterations? Teratology 46: 45-59.
15. Chen Y, Brunson KL, Adelmann G, Bender RA, Frotscher M, Baram TZ (2004). Hippocampal corticotropin releasing hormone: pre- and postsynaptic location and release by stress. Neuroscience 126: 533-540.
16. De Kloet ER (2004). Hormones and the stressed brain. Ann NY Acad Sci 1018: 1-15.
17. Diaz R, Fuxe K, Ogren SO (1997). Prenatal corticosterone treatment induces long-term changes in spontaneous and apomorphine-mediated motor activity in male and female rats. Neuroscience 81: 129-140.
18. Dielenberg RA, McGregor IS (2001). Defensive behavior in rats towards predatory odors: a review. Neurosci Biobehav Rev 25: 597-609.
19. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP (1999). Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180: 114-121.
20. French NP, Hagan R, Evans SF, Mullan A, Newnham JP (2004). Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 190: 588-595.
21. Gonzalez LE, Andrews N, File SE (1996). 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res 732: 145-153.
22. Gonzalez LE, Ouagazzal AM, File SE (1998). Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphe reveals differential GABAergic control in two animal tests of anxiety. Eur J Neurosci 10: 3673-3680.
23. Guinn DA, Atkinson MW, Sullivan L, Lee M, MacGregor S, Parilla BV et al (2001). Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. JAMA 286: 1581-1587.
24. Heilig M (2004). The NPY system in stress, anxiety and depression. Neuropeptides 38: 213-224.
25. Heilig M, Murison R (1987). Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul Pept 19: 221-231.
26. Hlinak Z, Krejci I (2002). MK-801 induced amnesia for the elevated plus-maze in mice. Behav Brain Res 131: 221-225.
27. Itoh J, Nabeshima T, Kameyama T (1991). Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur J Pharmacol 194: 71-76.
28. Kábová R, Liptáková S, Ŝ lamberová R, Pometlová M, Velíŝek L (1999). Age-specific N-methyl-D-aspartate-induced seizures: perspectives for the West syndrome model. Epilepsia 40: 1357-1369.
29. Kjelstrup KG, Tuvnes FA, Steffenach HA, Murison R, Moser EI, Moser MB (2002). Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci USA 99: 10825-10830.
30. MacArthur BA, Howie RN, Dezoete JA, Elkins J (1981). Cognitive and psychosocial development of 4-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 68: 638-643.
31. MacArthur BA, Howie RN, Dezoete JA, Elkins J (1982). School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 70: 99-105.
32. Makara GB, Haller J (2001). Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications. Prog Neurobiol 65: 367-390.
33. Masood A, Banerjee B, Vijayan VK, Ray A (2003). Modulation of stress-induced neurobehavioral changes by nitric oxide in rats. Eur J Pharmacol 458: 135-139.
34. Matthews SG (2000). Antenatal glucocorticoids and programming of the developing CNS. Pediatr Res 47: 291-300.
35. McGregor IS, Hargreaves GA, Apfelbach R, Hunt GE (2004). Neural correlates of cat odor-induced anxiety in rats: region-specific effects of the benzodiazepine midazolam. J Neurosci 24: 4134-4144.
36. McHugh SB, Deacon RM, Rawlins JN, Bannerman DM (2004). Amygdala and ventral hippocampus contribute differentially to mechanisms of fear and anxiety. Behav Neurosci 118: 63-78.
37. Meijer OC (2002). Coregulator proteins and corticosteroid action in the brain. J Neuroendocrinol 14: 499-505.
38. Mickley GA, Ferguson JL, Mulvihill MA, Nemeth TJ (1989). Progressive behavioral changes during the maturation of rats with early radiation-induced hypoplasia of fascia dentata granule cells. Neurotoxicol Teratol 11: 385-393.
39. Murphy MP, Rick JT, Milgram NW, Ivy GO (1995). A simple and rapid test of sensorimotor function in the aged rat. Neurobiol Learn Mem 64: 181-186.
40. Neal Jr CR, Weidemann G, Kabbaj M, Vazquez DM (2004). Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat. Am J Physiol Regul Integr Comp Physiol 287: R375-R385.
41. Ng PC, Wong GW, Lam CW, Lee CH, Fok TF, Wong MY et al (1999). Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants. Arch Dis Child Fetal Neonatal Ed 80: F213-F216.
42. NIH (1994). The effect of antenatal steroids for fetal maturation on perinatal outcomes-interim draft statement. NIH Consensus Statement Online, 1994 Feb 28-Mar 2, volume 12, number 2, pp 1-24. Accessed: October 11, 2005.
43. NIH (2000). Antenatal corticosteroids revisited: repeat courses. NIH Consensus Statement, 2000 August 17-18, volume 17, number 2, pp 1-10. Accessed: October 11, 2005.
44. Onodera K, Miyazaki S, Imaizumi M, Stark H, Schunack W (1998). Improvement by FUB 181, a novel histamine H3-receptor antagonist, of learning and memory in the elevated plus-maze test in mice. Naunyn Schmiedebergs Arch Pharmacol 357: 508-513.
45. Pellow S, Chopin P, File SE, Briley M (1985). Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14: 149-167.
46. Pellow S, File SE (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24: 525-529.
47. Perrin-Wolff M, Bertoglio J, Bressac B, Bohuon C, Pallardy M (1995). Structure-activity relationships in glucocorticoid-induced apoptosis in T lymphocytes. Biochem Pharmacol 50: 103-110.
48. Petersen MC, Collier CB, Ashley JJ, McBride WG, Nation RL (1983). Disposition of betamethasone in parturient women after intravenous administration. Eur J Clin Pharmacol 25: 803-810.
49. Podhorna J, Franklin KB (1998). Lesions of the pedunclopontine tegmental nucleus increase anxiety in rats. Neuroreport 9: 1783-1786.
50. Ravizza T, Friedman LK, Moshé SL, Velíšková J (2003). Sex differences in GABA(A)ergic system in rat substantia nigra pars reticulata. Int J Dev Neurosci 21: 245-254.
51. Ravizza T, Galanopoulou AS, Velíšková J, Moshé SL (2002). Sex differences in androgen and estrogen receptor expression in rat substantia nigra during development: an immunohistochemical study. Neuroscience 115: 685-696.
52. Reznikov AG, Nosenko ND, Tarasenko LV (1999). Prenatal stress and glucocorticoid effects on the developing gender-related brain. J Steroid Biochem Mol Biol 69: 109-115.
53. Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G et al (2004). Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci 24: 3051-3059.
54. Sajdyk TJ, Vandergriff MG, Gehlert DR (1999). Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol 368: 143-147.
55. Scheepens A, van de Waarenburg M, van den Hove D, Blanco CE (2003). A single course of prenatal betamethasone in the rat alters postnatal brain cell proliferation but not apoptosis. J Physiol 552: 163-175.
56. Schmand B, Neuvel J, Smolders-de Haas H, Hoeks J, Treffers PE, Koppe JG (1990). Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome. Pediatrics 86: 58-64.
57. Seckl JR (2000). Antenatal glucocorticoid therapy: a caveat to the applause. Clin Sci (Colch) 98: 127-128.
58. Seckl JR, Cleasby M, Nyirenda MJ (2000). Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Kidney Int 57: 1412-1417.
59. Smith JT, Waddell BJ (2000). Increased fetal glucocorticoid exposure delays puberty onset in postnatal life. Endocrinology 141: 2422-2428.
60. Smolders-de Haas H, Neuvel J, Schmand B, Treffers PE, Koppe JG, Hoeks J (1990). Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10- to 12-year follow-up. Pediatrics 86: 65-70.
61. Sorensen G, Lindberg C, Wortwein G, Bolwig TG, Woldbye DP (2004). Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. J Neurosci Res 77: 723-729.
62. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW (1994). Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci 14: 2579-2584.
63. Stott DH (1973). Follow-up study from birth of the effects of prenatal stresses. Dev Med Child Neurol 15: 770-787.
64. Takahashi LK, Turner JG, Kalin NH (1998). Prolonged stress-induced elevation in plasma corticosterone during pregnancy in the rat: implications for prenatal stress studies. Psychoneuro-endocrinology 23: 571-581.
65. Tamvakopoulos CS, Neugebauer JM, Donnelly M, Griffin PR (2002). Analysis of betamethasone in rat plasma using automated solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry. Determination of plasma concentrations in rat following oral and intravenous administration. J Chromatogr B 776: 161-168.
66. Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R et al (2000). Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA 97: 12852-12857.
67. Treit D, Pesold C, Rotzinger S (1993). Noninteractive effects of diazepam and amygdaloid lesions in two animal models of anxiety. Behav Neurosci 107: 1099-1105.
68. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC et al (1999). Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23: 99-103.
69. Tschenett A, Singewald N, Carli M, Balducci C, Salchner P, Vezzani A et al (2003). Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 18: 143-148.
70. Vallee M, MacCari S, Dellu F, Simon H, Le Moal M, Mayo W (1999). Long-term effects of prenatal stress and postnatal handling on age-related glucocorticoid secretion and cognitive performance: a longitudinal study in the rat. Eur J Neurosci 11: 2906-2916.
71. Vallee M, Mayo W, Dellu F, Le Moal M, Simon H, Maccari S (1997). Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion. J Neurosci 17: 2626-2636.
72. Velíšek L (2005a). Prenatal corticosteroid impact on hippocampus: implications for postnatal outcomes. Epilepsy Behav 7: 57-67.
73. Velíšek L (2005b). Prenatal betamethasone exposure suppresses kindling epileptogenesis in immature rats. In: Corcoran ME, Moshé SL (eds). Kindling 6. Springer: New York. pp 11-17.
74. Welberg LAM, Seckl JR (2001). Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 13: 113-128.
75. Welberg LAM, Seckl JR, Holmes MC (2001). Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 104: 71-79.
76. Welberg LAM, Seckl JR, Holmes MC (2000). Inhibition of 11β-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring. Eur J Neurosci 12: 1047-1054.
77. Yan XX, Toth Z, Schultz L, Ribak CE, Baram TZ (1998). Corticotropin-releasing hormone (CRH)-containing neurons in the immature rat hippocampal formation: light and electron microscopic features and colocalization with glutamate decarboxylase and parvalbumin. Hippocampus 8: 231-243.